Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSAKA
DRKS00000003Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Aug 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of tacrolimus in kidney allograft rejection, sponsored by Astellas Pharma. Started Aug 2008; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on DRKS00000003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000003.